RS
IMVT icon

R Squared’s Immunovant IMVT Stock Holding History

R Squared’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-570
Closed -$14.1K – 861
2024
Q4 		$14.1K Buy
+570
New +$16.2K 0.01% 1036

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

R Squared's IMVT Position: Q1 2025 in Review

R Squared sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 570 shares — an estimated $14.1K sold.

R Squared first reported a position in IMVT in Q4 2024 and held it in 1 quarter. The position peaked at $14.1K in Q4 2024. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • R Squared reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 570 Immunovant shares in Q1 2025, an estimated $14.1K.
  • R Squared first reported a position in Immunovant in Q4 2024 and held it in 1 quarter.
  • R Squared's Immunovant position peaked at $14.1K in Q4 2024.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.